<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2015-375-378</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2107</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Распространенность и клинические особенности подагры и болезни депонирования пирофосфата кальция у пациентов с острым артритом</article-title><trans-title-group xml:lang="en"><trans-title>THE PREVALENCE AND CLINICAL FEATURES OF GOUT AND CALCIUM PYROPHOSPHATE DEPOSITION DISEASE IN PATIENTS WITH ACUTE ARTHRITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеев</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseev</surname><given-names>M. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Владимиров</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vladimirov</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">ser_vlad@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Научно- исследовательский институт ревматологии им. В.А. Насоновой, Москва, Россия 115522 Москва, Каширское шоссе, 34А</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>10</day><month>09</month><year>2015</year></pub-date><volume>53</volume><issue>4</issue><fpage>375</fpage><lpage>378</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Елисеев М.С., Владимиров С.А., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Елисеев М.С., Владимиров С.А.</copyright-holder><copyright-holder xml:lang="en">Eliseev M.S., Vladimirov S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2107">https://rsp.mediar-press.net/rsp/article/view/2107</self-uri><abstract><p>Цель – изучить частоту и дать клиническую характеристику подагры и болезни депонирования пирофосфата кальция (БДПК) у больных острым артритом.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование включено 150 больных (97 мужчин и 53 женщины) с острым моно- или олигоартритом длительностью не более 2 нед, находившихся на амбулаторном приеме в ФГБНУ НИИР им. В.А. Насоновой. Средний возраст – 60,2±12,0 года (от 28 до 76 лет). Всем больным проводились пункция воспаленного сустава и идентификация кристаллов в синовиальной жидкости (СЖ) методом поляризационной микроскопии с компенсатором (Olympus CX31-P). Диагноз БДПК устанавливался в соответствии с критериями D. McCarty. Диагноз подагры выставлялся только при обнаружении кристаллов моноурата натрия (МУН) в СЖ.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. По результатам исследования у 51 (34%) пациента выявлена подагра, у 45 (30%) – БДПК, у 15 (14%) – сочетание подагры и БДПК, у 39 (26%) – другие заболевания: остеоартроз – у 15 (10%), ревматоидный артрит – у 6 (4%), септический артрит – у 5 (3%), псориатический артрит – у 5 (3%), анкилозирующий спондилоартрит – у 2 (1%), травма – 4 (3%), недифференцированный спондилоартрит – у 5 (3%). Среди больных подагрой было 40 мужчин и 11 женщин, среди больных с БДПК – 13 мужчин и 32 женщины. Пациенты с подагрой были моложе, чем с БДПК (соответственно 35,5±8,9 и 58,4±12,8 года; p&lt;0,05). У 34 (76,3%) больных с БДПК был артрит коленных, у 17 (30,3%) – голеностопных и у 4 (9%) – I плюснефаланговых суставов. Артрит развивался в течение нескольких часов у 90% пациентов с подагрой и у 33,3% больных с БДПК (p&lt;0,001). У больных подагрой достоверно чаще встречался моноартрит, тогда как при БДПК – олигоартрит (p&lt;0,05). Интенсивность боли по визуальной аналоговой шкале (ВАШ) у больных подагрой составила в среднем 78,4±12,5 мм, при БДПК – 54,32±22,02 мм (p&lt;0,05). Средняя длительность артрита у пациентов с БДПК составила 10,3±3,8 дня, у пациентов с подагрой – 3,4±2,1 дня (p&lt;0,05).</p></sec><sec><title>Заключение</title><p>Заключение. БДПК является наиболее частой (60%) причиной острого артрита у женщин и второй по частоте (13%) у мужчин (после подагры). Острый артрит у больных с БДПК развивается медленнее и сохраняется дольше, чем у больных подагрой.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to study the rate of gout and calcium pyrophosphate deposition disease (CPDD) and to provide their clinical characteristics in patients with acute arthritis.</p></sec><sec><title>Subjects and methods</title><p>Subjects and methods. The investigation enrolled 150 patients (97 men and 53 women) with acute mono- or oligoarthritis of no more than 2 weeks’ duration who had visited the Outpatient Department of V.A. Nasonova Research Institute of Rheumatology. Their mean age was 60.2±12.0 years (range, 28–76 years). All the patients underwent inflamed joint puncture and synovial fluid (SF) crystal identification by polarized microscopy using an Olympus CX31-P compensator.The diagnosis of CPDD was established in compliance with the criteria elaborated by D. McCarty. Gout was diagnosed only when sodium monourate (SMU) crystals were found in SF.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The investigation revealed gout in 51 (34%) patients, CPDD in 45 (30%), coincidence of gout and CPDD in 15 (14%), and 39 (26%) patients had other diseases: 15 (10%) – osteoarthritis, 6 (4%) – rheumatoid arthritis, 5 (3%) – septic arthritis, 5 (3%) – psoriatic arthritis, 2 (1%) – ankylosing spondyloarthritis, 4 (3%) – injury, and 5 (3%) – undifferentiated spondyloarthritis. There were 40 men and 11 women among the patients with gout and 13 men and 32 women among those with CPDD. The patients with gout were younger than those with CPDD (35.5±8.9 and 58.4±12.8 years, respectively; p &lt; 0.05). In the patients with CPDD, knee, ankle, and first metatarsophalangeal joint arthritis was present in 34 (76.3%), 17 (30.3%), and 4 (9%) cases, respectively. Arthritis developed within a few hours in 90% of the patients with gout and in 33.3% of those with CPDD (p &lt; 0.001). Monoarthritis was significantly more common in gout whereas oligoarthritis – in CPDD (p &lt; 0.05). Visual analog scale pain intensity averaged 78.4±12.5 mm and 54.32±22.02 mm (p &lt; 0.05), duration of arthritis – 10.3±3.8 days and 3.4±2.1 days (p &lt; 0.05) in gout and CPDD respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. CPDD is the most common (60%) cause of acute arthritis in women and the second most frequent (13%) cause in men (following gout). Acute arthritis develops more slowly and persists for a longer period of time in patients with CPDD than in those with gout.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>острый артрит</kwd><kwd>подагра</kwd><kwd>болезнь депонирования пирофосфата кальция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute arthritis</kwd><kwd>gout</kwd><kwd>calcium pyrophosphate deposition disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Барскова ВГ, Мукагова МВ, Северинова МВ и др. Диагностика подагры. Сибирский медицинский журнал. 2012;(5):132–5 [Barskova VG, Mukagova MV, Severinova MV, et al. Diagnosis of gout. Sibirskii meditsinskii zhurnal. 2012;(5):132–5 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Барскова ВГ, Мукагова МВ, Северинова МВ и др. Диагностика подагры. Сибирский медицинский журнал. 2012;(5):132–5 [Barskova VG, Mukagova MV, Severinova MV, et al. Diagnosis of gout. Sibirskii meditsinskii zhurnal. 2012;(5):132–5 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor WJ, Fransen J, Dalbeth N, et al. Performance of classification criteria for gout in early and established disease. Ann Rheum Dis. 2014 Oct 28. pii: annrheumdis-2014-206364. doi: 10.1136/annrheumdis-2014-206364 [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="en">Taylor WJ, Fransen J, Dalbeth N, et al. Performance of classification criteria for gout in early and established disease. Ann Rheum Dis. 2014 Oct 28. pii: annrheumdis-2014-206364. doi: 10.1136/annrheumdis-2014-206364 [Epub ahead of print].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563–70. doi: 10.1136/ard.2010.139105</mixed-citation><mixed-citation xml:lang="en">Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563–70. doi: 10.1136/ard.2010.139105</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study.I. The MAPPING study. Clin Exp Rheumatol. 2005;23(6):819–28.</mixed-citation><mixed-citation xml:lang="en">Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study.I. The MAPPING study. Clin Exp Rheumatol. 2005;23(6):819–28.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Barskova VG, Kudaeva FM, Bozhieva LA, et al. Comparison of three imaging techniques in diagnosis of chondrocalcinosis of the knees in calcium pyrophosphate deposition disease. Rheumatology (Oxford). 2013;52(6):1090–4. doi: 10.1093/rheumatology/kes433</mixed-citation><mixed-citation xml:lang="en">Barskova VG, Kudaeva FM, Bozhieva LA, et al. Comparison of three imaging techniques in diagnosis of chondrocalcinosis of the knees in calcium pyrophosphate deposition disease. Rheumatology (Oxford). 2013;52(6):1090–4. doi: 10.1093/rheumatology/kes433</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McCarty DJ. Calcium pyrophosphate dihydrate crystal deposition disease. Arthr Rheum. 1976;19 Suppl 3:275–85. doi: 10.1002/1529-0131(197605/06)19:3+&lt;275::AID-ART1780190702&gt;3.0.CO;2-0</mixed-citation><mixed-citation xml:lang="en">McCarty DJ. Calcium pyrophosphate dihydrate crystal deposition disease. Arthr Rheum. 1976;19 Suppl 3:275–85. doi: 10.1002/1529-0131(197605/06)19:3+&lt;275::AID-ART1780190702&gt;3.0.CO;2-0</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shmerling RH, Delbanco TL, Tosteson AN, et al. Synovial fluid tests. What should be ordered? JAMA 1990;264:1009–14. doi: 10.1001/jama.1990.03450080095039</mixed-citation><mixed-citation xml:lang="en">Shmerling RH, Delbanco TL, Tosteson AN, et al. Synovial fluid tests. What should be ordered? JAMA 1990;264:1009–14. doi: 10.1001/jama.1990.03450080095039</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jeng GW, Wang CR, Liu ST, et al. Measurement of synovial tumor necrosis factor-alpha in diagnosing emergency patients with bacterial arthritis. Am J Emerg Med. 1997;15:626–9. doi.org/10.1016/S0735-6757(97)90173-X</mixed-citation><mixed-citation xml:lang="en">Jeng GW, Wang CR, Liu ST, et al. Measurement of synovial tumor necrosis factor-alpha in diagnosing emergency patients with bacterial arthritis. Am J Emerg Med. 1997;15:626–9. doi.org/10.1016/S0735-6757(97)90173-X</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Parker JD, Capell HA. An acute arthritis clinic — one year’s experience. Br J Rheumatol. 1986;25:293. doi: 10.1093/rheumatology/25.3.293</mixed-citation><mixed-citation xml:lang="en">Parker JD, Capell HA. An acute arthritis clinic — one year’s experience. Br J Rheumatol. 1986;25:293. doi: 10.1093/rheumatology/25.3.293</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Freed JF, Nies KM, Boyer RS, et al. Acute monoarticular arthritis. A diagnostic approach. JAMA 1980;243:2314–6. doi: 10.1001/jama.1980.03300480034021</mixed-citation><mixed-citation xml:lang="en">Freed JF, Nies KM, Boyer RS, et al. Acute monoarticular arthritis. A diagnostic approach. JAMA 1980;243:2314–6. doi: 10.1001/jama.1980.03300480034021</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1301–11. doi: 10.1136/ard.2006.055251</mixed-citation><mixed-citation xml:lang="en">Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1301–11. doi: 10.1136/ard.2006.055251</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liote F, Lancrenon S, Lanz S, et al. GOSPEL: prospective survey of gout in France. Part I: design and patients characteristics (n=1003). Joint Bone Spine. 2012;79:464–70. doi: 10.1016/j.jbspin.2011.12.006</mixed-citation><mixed-citation xml:lang="en">Liote F, Lancrenon S, Lanz S, et al. GOSPEL: prospective survey of gout in France. Part I: design and patients characteristics (n=1003). Joint Bone Spine. 2012;79:464–70. doi: 10.1016/j.jbspin.2011.12.006</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Louthrenoo W, Sukitawut W. Calcium pyrophosphate dihydrate crystal deposition: a clinical and laboratory analysis of 91 Thai patients. J Med Asoc Thai. 1999;82(6):569–76.</mixed-citation><mixed-citation xml:lang="en">Louthrenoo W, Sukitawut W. Calcium pyrophosphate dihydrate crystal deposition: a clinical and laboratory analysis of 91 Thai patients. J Med Asoc Thai. 1999;82(6):569–76.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Кудаева ФМ, Владимиров СА, Елисеев МС и др. Особенности клинических проявлений болезни депонирования кристаллов пирофосфата кальция. Научно- практическая ревматология. 2014;52(4):405–9 [Kudaeva FM, Vladimirov SA, Eliseev MS, et al. The clinical manifestations of calcium pyrophosphate crystal deposition disease. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(4):405–9 (In Russ.)]. doi: 10.14412/1995-4484-2014-405-409</mixed-citation><mixed-citation xml:lang="en">Кудаева ФМ, Владимиров СА, Елисеев МС и др. Особенности клинических проявлений болезни депонирования кристаллов пирофосфата кальция. Научно- практическая ревматология. 2014;52(4):405–9 [Kudaeva FM, Vladimirov SA, Eliseev MS, et al. The clinical manifestations of calcium pyrophosphate crystal deposition disease. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(4):405–9 (In Russ.)]. doi: 10.14412/1995-4484-2014-405-409</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ramonda R, Musaccino E, Perissinoto E, et al. Prevalence of chondrocalcinosis in Italian subjects from northeastern Italy. The Pro.V.A. (PROgetto Veneto Anziani) study. Clin Exp Rheumatol. 2009;27(6):981–4.</mixed-citation><mixed-citation xml:lang="en">Ramonda R, Musaccino E, Perissinoto E, et al. Prevalence of chondrocalcinosis in Italian subjects from northeastern Italy. The Pro.V.A. (PROgetto Veneto Anziani) study. Clin Exp Rheumatol. 2009;27(6):981–4.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Neame RL, Carr AJ, Muir K, et al. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003;62(6):513–8. doi: 10.1136/ard.62.6.513</mixed-citation><mixed-citation xml:lang="en">Neame RL, Carr AJ, Muir K, et al. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003;62(6):513–8. doi: 10.1136/ard.62.6.513</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Felson DT, Anderson JJ, Naimark A, et al. The prevalence of chondrocalcinosis in the erderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol. 1989;16(9):1241–5.</mixed-citation><mixed-citation xml:lang="en">Felson DT, Anderson JJ, Naimark A, et al. The prevalence of chondrocalcinosis in the erderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol. 1989;16(9):1241–5.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Viriyavejkul P, Wilairatana V, Tanavalee A, et al. Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition desease who underwent total knee replacement surgery for osteoarthritis. Osteoarthritis Cartilage. 2007;1(2):232–5. doi: 10.1016/j.joca.2006.08.012</mixed-citation><mixed-citation xml:lang="en">Viriyavejkul P, Wilairatana V, Tanavalee A, et al. Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition desease who underwent total knee replacement surgery for osteoarthritis. Osteoarthritis Cartilage. 2007;1(2):232–5. doi: 10.1016/j.joca.2006.08.012</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Filippou G, Frediani B, Gallo A, et al. A «new» technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography. Ann Rheum Dis. 2007;66(8):1126–8. doi: 10.1136/ard.2007.069344</mixed-citation><mixed-citation xml:lang="en">Filippou G, Frediani B, Gallo A, et al. A «new» technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography. Ann Rheum Dis. 2007;66(8):1126–8. doi: 10.1136/ard.2007.069344</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
